TYVASO 1.74 MG/2.9 ML (0.6 MG/ML) Inhalation Solution

RxCUI: 857799
RxNorm name: TYVASO 1.74 MG/2.9 ML (0.6 MG/ML) Inhalation Solution
Display name: TYVASO 1.74 MG/2.9 ML (0.6 MG/ML) Inhalation Solution
Full name: TYVASO 1.74 MG/2.9 ML (0.6 MG/ML) Inhalation Solution
Term type: PSN
Status: DailyMed mapping
Updated: 2026-06-04 23:39:21

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
TYVASO	TREPROSTINIL	United Therapeutics Corporation	cbc31ab1-a80f-4b50-a3b1-39910b0fb609	2026-04-14	Warnings, Adverse reactions	Exact identifier rxcui: 857799

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
cbc31ab1-a80f-4b50-a3b1-39910b0fb609	TYVASO 1.74 MG/2.9 ML (0.6 MG/ML) Inhalation Solution	PSN	32	These highlights do not include all the information needed to use TYVASO safely and effectively. See full prescribing information for TYVASO. TYVASO ® (treprostinil) inhalation solution, for oral inhalation use Initial U.S. Approval: 2002	20260414
cbc31ab1-a80f-4b50-a3b1-39910b0fb609	treprostinil 0.6 MG/ML Inhalation Solution [Tyvaso]	SBD	32	These highlights do not include all the information needed to use TYVASO safely and effectively. See full prescribing information for TYVASO. TYVASO ® (treprostinil) inhalation solution, for oral inhalation use Initial U.S. Approval: 2002	20260414
cbc31ab1-a80f-4b50-a3b1-39910b0fb609	Tyvaso 1.74 MG per 2.9 ML Inhalation Solution	SY	32	These highlights do not include all the information needed to use TYVASO safely and effectively. See full prescribing information for TYVASO. TYVASO ® (treprostinil) inhalation solution, for oral inhalation use Initial U.S. Approval: 2002	20260414
cbc31ab1-a80f-4b50-a3b1-39910b0fb609	Tyvaso 0.6 MG/ML Inhalation Solution	SY	32	These highlights do not include all the information needed to use TYVASO safely and effectively. See full prescribing information for TYVASO. TYVASO ® (treprostinil) inhalation solution, for oral inhalation use Initial U.S. Approval: 2002	20260414